FR EA

Extract to table

Pull the structured facts out of a document: parties, dates, amounts, obligations.

Extract to table / closing-binder-index.docx
closing-binder-index.docx · 1018-00004

Parties

HARKNESS LLP
Penterra Pharmaceuticals Corp
CONDITIONS PRECEDENT SA
Callahan LLP
Hargrove LLP

Dates

June 28, 2023
July 5, 2023
July 18, 2023
July 21, 2023
March 31, 2024
August 14, 2023
March 15, 2023
April 1, 2023
March 20, 2023
April 7, 2023

Amounts

$80,000,000
$52,000
$13,000
$75,000
$37,500
$500,000
$15,000,000
$5,000,000
$20,000,000
$25,000,000

Obligations

No settlement may be agreed to without the prior written consent of the indemnified party, which consent shall not be unreasonably withheld, conditioned, or delayed
and each participating Veridian Network site (c) Certificate Exchange Deadline: All certificates of insurance shall be exchanged within 15 business days of execution of the MCTA (i
The parties shall comply with all applicable requirements of HIPAA and shall enter into Business Associate Agreements as necessary
Nothing in the MCTA or this Exhibit G shall be construed to transfer ownership of any party's pre-existing intellectual property to any other party
(c) Joint Inventions: Inventions that are jointly developed by personnel of Penterra and personnel of a participating site or the Veridian Network shall be governed by the intellectual Property Side Letter executed concurrently with the MCTA (see Tab 24 of this closing binder)
• If Penterra identifies patentable subject matter, the investigator shall delay submission for up to an additional 90 calendar days beyond the initial 60-day review period to permit Penterra to file appropriate patent applications